• Profile

Efficacy and tolerance of botulinum toxin injections after sacral nerve stimulation failure for idiopathic overactive bladder

Neurourology and Urodynamics Mar 08, 2020

Baron M, et al. - The present study was performed to analyze the tolerance and efficacy of BoNT-A injection after the failure of sacral nerve modulation (SNM) for overactive bladder (iOAB). Between January 2004 and December 2017, researchers carried out a retrospective multicentric analysis of all individuals who had received either onabotulinumtoxinA or abobotulinumtoxinA intradetrusor injection for iOAB after SNM failure. A total of 76 individuals (62 females) were recruited in this study. The primary endpoint included the percentage of success of first BoNT-A injection (either resolution of their urinary incontinence or their frequency or more than 50% reduction in frequency). Results of urodynamic studies, complications, the total number of injections, causes of withdrawal, and subsequent treatment were considered as the secondary endpoints. The evidence showed that BoNT-A can be applied in SNM nonresponders with a success rate of 43.4% but is correlated with a high long-term discontinuation rate.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen